Reference
Dalvin LA, et al. Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy. American Journal of Ophthalmology Case Reports 26: Jun 2022. Available from: URL: https://www.sciencedirect.com/science/article/pii/S2451993622003000?via%3Dihub
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1943, 466 (2023). https://doi.org/10.1007/s40278-023-33349-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-33349-7